Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

KK SHAH HOSPITALS LTD.

NSE : NABSE : 544013ISIN CODE : INE0OH401016Industry : Hospital & Healthcare ServicesHouse : Private

BSE37.050 (0 %)

PREV CLOSE ( ) 37.05

OPEN PRICE ( ) 37.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 9000

TODAY'S LOW / HIGH ( )37.05 37.05

52 WK LOW / HIGH ( ) 31.651.94

NSE

This Company is not listed in NSE

Select year

Particulars

Mar 2025

Mar 2024

Mar 2023

Operational & Financial Ratios

Earnings Per Share (Rs)

-0.48

0.89

0.45

CEPS(Rs)

1.01

1.45

0.65

DPS(Rs)

0.00

Book NAV/Share(Rs)

19.70

20.70

10.48

Tax Rate(%)

-0.25

12.90

25.15

Margin Ratios

Core EBITDA Margin(%)

1.46

8.71

17.31

EBIT Margin(%)

-3.63

10.15

13.80

Pre Tax Margin(%)

-3.63

10.13

13.75

PAT Margin (%)

-3.64

8.83

10.29

Cash Profit Margin (%)

7.62

14.34

14.87

Performance Ratios

ROA(%)

-2.15

6.03

3.89

ROE(%)

-2.38

6.33

4.28

ROCE(%)

-2.37

7.28

5.74

Asset Turnover(x)

0.59

0.68

0.38

Sales/Fixed Asset(x)

1.63

4.39

1.53

Working Capital/Sales(x)

-8.75

4.47

1.19

Efficiency Ratios

Fixed Capital/Sales(x)

0.61

0.23

0.66

Receivable days

3.41

4.11

8.32

Inventory Days

0.00

Payable days

Valuation Parameters

PER(x)

0.00

55.11

0.00

PCE(x)

46.18

33.93

0.00

Price/Book(x)

2.36

2.37

0.00

Yield(%)

0.00

EV/Net Sales(x)

3.48

4.75

1.34

EV/Core EBITDA(x)

45.58

30.32

7.30

EV/EBIT(x)

-95.92

46.78

9.72

EV/CE(x)

2.33

2.32

0.56

M Cap / Sales

3.52

4.86

0.00

Growth Ratio

Net Sales Growth(%)

30.82

224.67

0.00

Core EBITDA Growth(%)

-36.27

176.77

0.00

EBIT Growth(%)

-146.73

138.83

0.00

PAT Growth(%)

-153.89

178.40

0.00

EPS Growth(%)

-153.89

98.67

0.00

Financial Stability Ratios

Total Debt/Equity(x)

0.00

Current Ratio(x)

0.60

3.86

4.42

Quick Ratio(x)

0.60

3.86

4.42

Interest Cover(x)

-1631.00

698.10

324.78

Total Debt/Mcap(x)

0.00